Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age5-17
SponsorThe University of Texas Health Science Center, Houston

About this trial

The purpose of this study is to compare the efficacy of laser photobiomodulation and "Magic Mouthwash" for treatment of pain in pediatric patients with aphthous ulcers , to assess how photobiomodulation influences the rate of healing of aphthous ulcers in pediatric patients and to measure changes in pain levels reported by pediatric patients undergoing photobiomodulation treatment for aphthous ulcers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient/guardian speaks either English or Spanish

Patient presenting with one or more aphthous ulcers in their mouth, identified during a scheduled dental appointment

No previous PBM treatment to the presenting aphthous ulcer(s)

Guardian able to partake in a follow-up phone call in either the English or Spanish language

Disqualifiers

Patient presents with aphthous ulcers recently treated with PBM

Patient presents with herpes labialis (cold sores)

Patients presents with systemic disease that affects soft tissue/mucous healing

Trial design

Design model

Parallel

Treatments tested in this trial

  • PBM Therapy

    Device

    patients will receive PBM therapy using the Biolase Epic pro laser. An average power of 0.6w (peak power = 80w, rep. rate= 20Hz). Each aphthous ulcer will be irradiated one time for a total of 30 seconds via continuous wave.

  • Maalox plus Benadryl

    Drug

    1:1 mixture of Maalox and Benadryl will be applied to the ulcer as needed for pain. Applications typically will be applied before eating to form a dissolvable oral band-aid that lasts for up to 30 minutes. 10 milliliters of 1:1 Maalox: Benadryl solution will be provided to the family. During the presenting appointment, the patient/family will be shown how to use the 1:1 Maalox: Benadryl solution. It will be applied topically with no rinsing needed.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: PBM TherapyExperimental treatment 2 interventions
Group B: Standard of careActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Quality of life as assessed by questionnaire (Likert scale)

This is a 6 item questionnaire and each is scored from 1-5, maximum score of 30,higher number indicating better outcome

Time frame
Baseline, immediately after treatment(about 5 minutes), 24 hours after treatment
2

Pain as assessed by how frequently patient complains of pain (Likert scale)

Time frame
upto 24 hours after treatment
3

Pain as assessed by number of participants who are using any over-the-counter or prescription medications, topical treatments, or oral rinses to treat aphthous ulcer pain

Time frame
upto 24 hours after treatment

Secondary outcomes

1

Change in lesion size as an indication of healing as assessed by clinical intraoral images of the aphthous ulcer and measuring tool

Time frame
pre-treatment and immediately post-treatment(about 5 minutes)
2

Change in pain as assessed by a Visual Analogue Scale (VAS) for control group

Pain level is scored from 0(no pain) to 10(worst pain)

Time frame
Baseline, 24 hours after treatment
3

Pain as assessed by a Visual Analogue Scale (VAS) for experimental group

Pain level is scored from 0(no pain) to 10(worst pain)

Time frame
Baseline, immediately after PBM(about 5 minutes), 24 hours after treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.